Qilu Hospital of Shandong University Dezhou Hospital, Dezhou, Shandong, China.
Mol Genet Genomic Med. 2024 May;12(5):e2420. doi: 10.1002/mgg3.2420.
This study aims to report a severe phenotype of Arboleda-Tham syndrome in a 20-month-old girl, characterized by global developmental delay, distinct facial features, intellectual disability. Arboleda-Tham syndrome is known for its wide phenotypic spectrum and is associated with truncating variants in the KAT6A gene.
To diagnose this case, a combination of clinical phenotype assessment and whole-exome sequencing technology was employed. The genetic analysis involved whole-exome sequencing, followed by confirmation of the identified variant through Sanger sequencing.
The whole-exome sequencing revealed a novel de novo frameshift mutation c.3048del (p.Leu1017Serfs*17) in the KAT6A gene, which is classified as likely pathogenic. This mutation was not found in the ClinVar and HGMD databases and was not present in her parents. The mutation leads to protein truncation or activation of nonsense-mediated mRNA degradation. The mutation is located within exon 16, potentially leading to protein truncation or activation of nonsense-mediated mRNA degradation. Protein modeling suggested that the de novo KAT6A mutation might alter hydrogen bonding and reduce protein stability, potentially damaging the protein structure and function.
This study expands the understanding of the genetic basis of Arboleda-Tham syndrome, highlighting the importance of whole-exome sequencing in diagnosing cases with varied clinical presentations. The discovery of the novel KAT6A mutation adds to the spectrum of known pathogenic variants and underscores the significance of this gene in the syndrome's pathology.
本研究旨在报告一例 20 月龄女孩患 Arboleda-Tham 综合征的严重表型,其特征为全面发育迟缓、独特的面部特征和智力障碍。Arboleda-Tham 综合征具有广泛的表型谱,与 KAT6A 基因的截断变异相关。
为诊断该病例,采用临床表型评估与全外显子组测序技术相结合的方法。基因分析包括全外显子组测序,随后通过 Sanger 测序确认鉴定的变异。
全外显子组测序揭示了 KAT6A 基因中的一个新的移码突变 c.3048del(p.Leu1017Serfs*17),该突变被归类为可能致病性突变。该突变未在 ClinVar 和 HGMD 数据库中发现,也不存在于其父母中。该突变导致蛋白截断或无义介导的 mRNA 降解激活。突变位于外显子 16 内,可能导致蛋白截断或无义介导的 mRNA 降解激活。蛋白建模提示新的 KAT6A 突变可能改变氢键并降低蛋白稳定性,从而破坏蛋白结构和功能。
本研究扩展了对 Arboleda-Tham 综合征遗传基础的认识,强调了全外显子组测序在诊断具有不同临床表现的病例中的重要性。新发现的 KAT6A 突变增加了已知致病性变异的谱,并强调了该基因在该综合征发病机制中的重要性。